{
  "meta": {
    "title": "Pharmacology_Free_Revision_Test_10",
    "url": "https://brainandscalpel.vercel.app/pharmacology-free-revision-test-10-6de109e0.html",
    "scrapedAt": "2025-11-30T11:08:53.971Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous digoxin</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous adenosine</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous amiodarone</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous verapamil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38 yr old female, diagnosed of ventricular tachycardia with rapid hemodynamic deterioration was given electric conversion. After the patient gets stabilized, Intravenous lignocaine was administered which failed to control the patient's heart rate. What is the next step in management?</span></p>",
      "unique_key": "Q185790",
      "question_audio": null,
      "question_video": null,
      "map_id": 185790,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Cardioversion(Electrical conversion): Treatment of choice for VT with hemodynamic instability</p><p>Increasing lignocaine dose not recommended</p><p>Intravenous amiodarone is used as second line therapy following failure of intravenous lignocaine.</p><p>For recurrent ventricular tachycardia, amiodarone or sotalol is preferred.</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 578</p>",
      "correct_choice_id": 3,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxcarbazepine has more chances of dilutional hyponatremia than carbamazepine</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxcarbazepine blocks N-, P- and R- type Calcium channels, whereas carbamazepine blocks L-type calcium channels</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxcarbazepine is not an auto-inducer of metabolism</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxcarbazepine causes less hypothyroidism than carbamazepine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">False statement regarding advantages of oxcarbazepine over carbamazepine is</span></p>",
      "unique_key": "Q185791",
      "question_audio": null,
      "question_video": null,
      "map_id": 185791,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>Oxcarbazepine:</strong></p><ul><li><strong>No auto-induction</strong> of metabolism</li><li><strong>Blocks</strong> N-, P- and R- type <strong>calcium channels</strong></li><li>Dilutional Hyponatremia, Hypothyroidism (More than carbamazepine)</li><li>Reduction in bone density (&ge; carbamazepine)</li></ul><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 442</p>",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Enfuvirtide is given via sub-cutaneous route</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Trofile assay needs to be done before administering enfuvirtide</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Maraviroc acts specifically against CCR-5</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Maraviroc has got no activity against CXCR-4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is false regarding entry inhibitors?</span></p>",
      "unique_key": "Q185792",
      "question_audio": null,
      "question_video": null,
      "map_id": 185792,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>Maraviroc</strong> has got <strong>activity against CCR-5 </strong>but no activity against CXCR-4 (which is preferred by majority of HIV virions for binding for their entry). <strong>To determine whether Maraviroc will be effective or not, Trofile assay</strong> needs to be done before administering it to <strong>identify the tropism of patient&rsquo;s HIV.</strong></p><p>Reference: Goodman and Gilman's The Pharmacological Basis of therapeutics, 14<sup>th</sup> edition, page no. 1258</p>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Omalizumab</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Reslizumab</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Benralizumab</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Adalimumab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are biologics used as add on therapy for bronchial asthma except:</span></p>",
      "unique_key": "Q185793",
      "question_audio": null,
      "question_video": null,
      "map_id": 185793,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/4E(i).png\"><br><img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/4E(ii).png\"><br><img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/4E(iii).png\"><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 230</p>",
      "correct_choice_id": 34,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Allopurinol</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Colchicine</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Rasburicase</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Probenecid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 67 yr old with IHD, HT, hyperlipidemia and atrial fibrillation visited a general practitioner for yearly health check-up and was found to have elevated uric acid levels. He was diagnosed to have asymptomatic gout. However, based on his elevated uric acid levels, he was prescribed an anti-gout drug. Two weeks later, he was admitted in hospital with features as in the image. Which drug would have caused this?<br><img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/5Q.png\"></span></p>",
      "unique_key": "Q185794",
      "question_audio": null,
      "question_video": null,
      "map_id": 185794,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>This is a case of <strong>Allopurinol hypersensitivity syndrome</strong>, which is commonly seen in patients who have <strong>HLA *B 5801 allele</strong>. There is a mortality risk of &lt;25% mortality</p><p>The cutaneous reaction caused by allopurinol is predominantly a pruritic, erythematous, or maculopapular eruption, but occasionally, the lesion is urticarial or purpuric. Rarely, toxic epidermal necrolysis or Stevens-Johnson syndrome occurs, which can be fatal.</p><p>The risk for Stevens-Johnson syndrome is limited primarily to the first 2 months of treatment. Because the rash may precede severe hypersensitivity reactions, patients who develop a rash should discontinue allopurinol. Among polymorphic genetic factors that appear to contribute to such delayed hypersensitivity reactions is the human leucocyte antigen B*5801 allele (HLA-B*5801)</p><p>Reference: Goodman and Gilman's The Pharmacological Basis of therapeutics, 14<sup>th</sup> edition, page no. 849</p>",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">&alpha;1, &alpha;2</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">&alpha;1, &alpha;2, &beta;1</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">&beta;1, &beta;2</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">M2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Cardiovascular effects of a new drug (X) that activates autonomic receptors are shown below<br><img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/6Q.png\"><p>The most probable receptor affinities of the drug X would be</p></span></p>",
      "unique_key": "Q185795",
      "question_audio": null,
      "question_video": null,
      "map_id": 185795,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>A decrease in mean blood pressure, an increase in pulse pressure, plus a marked increase in heart rate are characteristic of a drug such as isoproterenol. Peripheral vascular resistance and mean BP are decreased because of activation of &beta;2 receptors in the vasculature.</p><p>Systolic BP decreases to a lesser extent than diastolic BP because of activation of &beta;1 receptors in the heart, leading to an increase in stroke volume, as well as the increase in heart rate.</p><p><strong>Beta receptors in the heart:</strong></p><ul><li>The human heart expresses <strong>&beta;<sub>1</sub>- and &beta;<sub>2</sub>-</strong>adrenergic receptors at a ratio of about <strong>70:30</strong>; both subtypes <strong>increase heart rate and contractility</strong>.</li><li>In addition, <strong>&beta;<sub>3</sub>-receptors</strong> have been described to mediate <strong>negative inotropic</strong> effects, but their role remains uncertain.</li><li>All three subtypes appear to occur in <strong>cardiomyocytes,</strong> but they seem to possess distinct intracellular signaling and functional properties</li></ul><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 142-143</p>",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Alliskiren decreases mortality to a lesser extent than ACE inhibitors</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Tenelegliptin benefits patients with both heart failure and T2DM</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Milrinone is currently approved for prophylaxis of chronic heart failure</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Bucindolol, a beta blocker, does not decrease mortality in stable severe heart failure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is TRUE regarding management of a patient with heart failure?</span></p>",
      "unique_key": "Q185796",
      "question_audio": null,
      "question_video": null,
      "map_id": 185796,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong>Bucindolol</strong> is a <strong>non-selective &beta;-adrenergic receptor blocker</strong> with <strong>&alpha;-1 blocker</strong> properties and <strong>mild intrinsic sympatholytic</strong></li><li>The Beta-Blocker Evaluation of Survival Trial <strong>(BEST</strong>), which is the largest clinical trial of bucindolol in patients with heart failure, was terminated prematurely as the drug <strong>failed to show an overall mortality benefit</strong>.</li><li>However, benefits on cardiac mortality and re-hospitalization rates were observed in the BEST trial.</li></ul><p>Reference: Goodman and Gilman's The Pharmacological Basis of therapeutics, 14<sup>th</sup> edition, page no. 283</p>",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin should be continued until the third trimester</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin should be replaced with aspirin at analgesic doses.</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">All medications that affect the blood should be discontinued.</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin should be replaced with heparin.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman who has a mechanical heart valve and on warfarin wishes to get pregnant soon. What advice should she receive regarding her antithrombotic medication during the anticipated pregnancy?</span></p>",
      "unique_key": "Q185797",
      "question_audio": null,
      "question_video": null,
      "map_id": 185797,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>Discontinuing warfarin</strong> is appropriate <strong>during pregnancy</strong> because it is a known teratogen that causes <strong>bone dysmorphogenesis</strong>. The patient will need continued protection against thrombus formation. H<strong>eparin (or a related low molecular weight compound)</strong> is usually advised, even though the drug will require parenteral administration and can cause thrombocytopenia.</p><p><strong>Fetal Warfarin syndrome:</strong></p><ul><li>Also known as Warfarin embryopathy or di Sala syndrome</li><li>It is primarily characterised by:<ul><li>Nasal hypoplasia</li><li>Limbal Skeletal abnormalities<ul><li>Short limbs and digits (brachydactyly)</li><li>Stippled epiphyses</li></ul></li></ul></li></ul><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 664-670</p>",
      "correct_choice_id": 74,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Previous hysterectomy</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Recurrent vaginitis</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Rheumatoid arthritis</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Strong family history of breast cancer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old postmenopausal woman has evidence of low bone mineral density(BMD). Her physician is considering therapy with raloxifene or a combination of conjugated estrogens and medroxyprogesterone acetate. Which of the following patient characteristics is most likely to influence the decision to choose raloxifene?</span></p>",
      "unique_key": "Q185798",
      "question_audio": null,
      "question_video": null,
      "map_id": 185798,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>Estrogen replacement</strong> has been widely recommended in peri-/post-menopausal women for:</p><ul><li>Prevention and treatment of <strong>osteoporosis</strong></li><li>Reduction of the risk of mortality from <strong>cardiovascular disease</strong></li><li>Improvement of <strong>lipid profile</strong></li><li>Amelioration of the <strong>signs and symptoms of menopause</strong></li><li>Possible protection against the development of <strong>Alzheimer's disease</strong></li></ul><ul><li><strong>Raloxifene</strong> has the ability to bind to and activate the estrogen receptor while exhibiting tissue-specific effects distinct from estradiol. It is therefore labeled as a <strong>SERM(Selective Estrogen Receptor Modulator). </strong><ul><li>Has <strong>estrogenic activity</strong> on bone and lipids which is beneficial:<ul><li><strong>Improves bone mineral density</strong> and protect against osteoporosis</li><li><strong>Lowers</strong> total and low-density lipoprotein<strong>(LDL)</strong> <strong>cholesterol levels</strong></li></ul></li><li>Has <strong>anti-estrogenic activity</strong> on <strong>endometrial and breast tissue.</strong><ul><li>Raloxifene has <strong>antagonist effect in breast</strong> In patients with a strong family history of breast cancer, raloxifene may be a better choice because it has <strong>protective effects against breast cancer.</strong></li><li>Raloxifene has <strong>n</strong><strong>eutral effect on the uterus</strong>. Therefore, option A(hysterectomy) has no influence in the decision-making for this patient.</li></ul></li></ul></li></ul><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 338-339</p>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Ofloxacin</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Pefloxacin</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Levofloxacin</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Lomefloxacin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the fluoroquinolones is contraindicated in liver disease?</span></p>",
      "unique_key": "Q185799",
      "question_audio": null,
      "question_video": null,
      "map_id": 185799,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Salient Features Of Fluoroquinolones</p><br><img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/10E.png\"><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 763</p>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Trimetazidine</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Ivabradine</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Ranolazine</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta blockers</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drug blocks late sodium channels in cardiac muscle?</span></p>",
      "unique_key": "Q185800",
      "question_audio": null,
      "question_video": null,
      "map_id": 185800,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/11E.png\"><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 600</p>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Acarbose</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Exenatide</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Glipizide</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Pioglitazone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs is taken during the first part of a meal for the purpose of delaying the absorption of dietary carbohydrates?</span></p>",
      "unique_key": "Q185801",
      "question_audio": null,
      "question_video": null,
      "map_id": 185801,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>To be absorbed, carbohydrates must be <strong>converted into monosaccharides</strong> by the action of <strong>&alpha;</strong><strong>-glucosidase</strong> enzymes in the gastrointestinal tract.</p><p><strong>Acarbose inhibits </strong><strong>&alpha;</strong><strong>-glucosidase</strong> and <strong>delays carbohydrate absorption</strong>. This helps in preventing post-prandial blood sugar spike.</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 301</p>",
      "correct_choice_id": 111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Ticlopidine</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Theophylline</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Tacrolimus</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Therapeutic drug monitoring is not scientific for which of the following drug?</span></p>",
      "unique_key": "Q185802",
      "question_audio": null,
      "question_video": null,
      "map_id": 185802,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Therapeutic drug monitoring is not scientific when the agent is a <strong>hit and run drug. </strong>Ticlopidine is an example of hit and run drug (P2Y12 inhibitor). the action of the drug persists even in the absence of detectable plasma concentration.</p><p>Other examples of <strong>hit and run drugs</strong> include:</p><p>Mnemonic: <strong><u>GRAM</u></strong> <strong><u>P</u></strong>osi<strong><u>T</u></strong>ive</p><p>G &ndash; <strong>G</strong>uanethidine</p><p>R &ndash; <strong>R</strong>eserpine</p><p>A &ndash; <strong>A</strong>spirin</p><p>M &ndash; <strong>M</strong>AO inhibitors</p><p>P &ndash; <strong>P</strong>roton pump inhibitors</p><p>T - <strong>T</strong>iclopidine</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 678</p>",
      "correct_choice_id": 121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase the dose of furosemide</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Add a thiazide diuretic</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Stop furosemide and change to thiazide diuretic</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Add an aldosterone receptor antagonist</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 54 yr old male diagnosed with hepatic cirrhosis was given furosemide for relieving his edema. However, due to unresponsiveness, he reported back to the physician. What is the next step in management?</span></p>",
      "unique_key": "Q185803",
      "question_audio": null,
      "question_video": null,
      "map_id": 185803,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Hepatic cirrhosis induced edema is usually not responsive to loop diuretics due to <strong>decreased secretion of drug into tubular fluid and high aldosterone levels.</strong> Some patients might be benefitted from adding an aldosterone receptor antagonist agent with the loop diuretic.</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 633-634</p>",
      "correct_choice_id": 134,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">For urticaria, it is quite effective before exposure than after exposure</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Second generation drugs are more efficacious than first generation agents</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">These drugs are largely ineffective against bronchial asthma</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">For atopic dermatitis, these drugs reduces awareness of itching</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is NOT TRUE regarding anti-histamincs and their use in allergic reactions?</span></p>",
      "unique_key": "Q185804",
      "question_audio": null,
      "question_video": null,
      "map_id": 185804,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Second-generation and first-generation antihistamines have equal efficacy in the treatment of allergic reactions.</p><p>But second-generation agents are preferred as they have better safety profile (Less sedation and safe operation of machinery)</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 181</p>",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Cisplatin</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Vincristine</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Capecitabine</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitomycin C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presented with the lesions as shown in the image. Which of the following drugs could have caused this?<br><img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/16Q.png\"></span></p>",
      "unique_key": "Q185805",
      "question_audio": null,
      "question_video": null,
      "map_id": 185805,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>The image shows '<strong>Hand and Foot syndrome'</strong>.</p><p>Drugs causing hand and foot syndrome:</p><ol><li>5-FU</li><li>Capecitabine</li><li>Pemetrexed</li><li>Doxorubicin</li></ol><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 923</p>",
      "correct_choice_id": 153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Netarsudil</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Chloroquine</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Indomethacin</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Most common cause of this adverse effect is?<br><img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/17Q.png\"></span></p>",
      "unique_key": "Q185806",
      "question_audio": null,
      "question_video": null,
      "map_id": 185806,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>This is <strong>Cornea Verticillata or Vortex keratopathy</strong> (whorl-like pattern of golden brown or gray deposits in the inferior inter-palpebral portion of the cornea)</p><p>Drugs that bind with the cellular lipids of the basal epithelial layer of the cornea due to their cationic, amphiphilic properties and are capable of producing this.</p><p>Common causes:</p><p><strong>Amiodarone &gt; Chloroquine / HCQ</strong> &gt; Indomethacin &gt; Phenothiazines. Netarsudil, a new anti-glaucoma drug also causes corneal verticillata.</p><p>Reference: Goodman and Gilman's The Pharmacological Basis of therapeutics, 14<sup>th</sup> edition, page no. 687</p>",
      "correct_choice_id": 164,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Tenofovir</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Lamivudine</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Efavirenz</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Lopinavir/Ritonavir</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38 yr old male, a PLHIV(People Living with HIV/AIDS), was put under highly active anti-retroviral therapy(HAART). After a few years of regular treatment, the patient came for follow-up and complained of bone pain. X-ray was advised which came back as shown in the image. Which of the following drugs would have been the cause of it?<br><img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/18Q.png\"></span></p>",
      "unique_key": "Q185807",
      "question_audio": null,
      "question_video": null,
      "map_id": 185807,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>Tenofovir disoproxil fumarate</strong> is associated with <strong>severe nephrotoxicity and demineralization of bone (Osteopenia)</strong>, which is visible in this X-ray image as increased translucency in the bone matrix.</p><p>Both nephrotoxicity and bone demineralization is less common with Tenofovir alafenamide.</p><p>Reference: Goodman and Gilman's The Pharmacological Basis of therapeutics, 14<sup>th</sup> edition, page no. 1232</p>",
      "correct_choice_id": 171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Continue the same treatment</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase the dose of Telmisartan</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Change over to Olmesartan</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Refer the patient to another colleague</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40 yr old female started on Telmisartan returns to the OPD, after 2 weeks of therapy, with complaints of failure of therapy. She had tested her BP in home, and it had not decrease to the optimum level. What is the next step in management?</span></p>",
      "unique_key": "Q185808",
      "question_audio": null,
      "question_video": null,
      "map_id": 185808,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>The <strong>full effect of AT1 receptor blockers</strong> on blood pressure typically is not observed until about <strong>4 weeks after the initiation</strong> of therapy.</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 537</p>",
      "correct_choice_id": 181,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Flecainide</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Sotalol</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Verapamil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-yr old male patient complains of pounding heartbeat for the past few days which is accompanied by mild chest discomfort. The ECG recording of the patient is attached herewith. Which of the following drugs should not be administered to this patient?<br><img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/20Q.png\"></span></p>",
      "unique_key": "Q185809",
      "question_audio": null,
      "question_video": null,
      "map_id": 185809,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>This is a case of <strong>WPW syndrome(Wolff-P</strong><em><strong>arkinson-White syndrome)</strong></em>.</p><p><strong>Verapamil and digoxin</strong> should <strong>NOT</strong> be used in WPW syndrome, as they <strong>increase</strong> <strong>antegrade conduction </strong>through the <strong>accessory pathway</strong> by <strong>increasing the refractory period in the AV node</strong>.</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 580</p>",
      "correct_choice_id": 194,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Dabigatran</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Rivaroxaban</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Apixaban</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Edoxaban</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following DOACs(Direct Oral Anti-Coagulants), for preventing stroke in atrial fibrillation, should be administered with food?</span></p>",
      "unique_key": "Q185810",
      "question_audio": null,
      "question_video": null,
      "map_id": 185810,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>40% increased absorption</strong> of <strong>Rivaroxaban</strong> occurs when taken along with food.</p><p><strong>Dose of DOACs:</strong></p><ol><li>Dabigatran &ndash; 110/150 mg BD</li><li>Rivaroxaban - 20 mg OD</li><li>Apixaban - 5 mg BD</li><li>Edoxaban - 60 mg OD</li></ol><br><img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/21E.png\"><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 670-671</p>",
      "correct_choice_id": 202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Left ventricular hypertrophy</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Asymptomatic atherosclerosis</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic aneurysm</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Isolated systolic hypertension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Beta blockers are preferred in which of the following specific patient populations diagnosed with hypertension?</span></p>",
      "unique_key": "Q185811",
      "question_audio": null,
      "question_video": null,
      "map_id": 185811,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li>In case of <strong>aortic aneurysm, hypertension must be controlled</strong> to decrease the risk of myocardial infarction, stroke, heart failure, death from cardiovascular causes, and aortic dissection.</li><li>In persons with thoracic aortic aneurysm, BP should be lowered to less than 130/80 mmHg</li><li>A <strong>beta blocker plus an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker</strong> should be administered to these persons.</li><li>Effect Beta blockers:</li><ul><li>Lower blood pressure and also reduce peak left ventricular ejection rate.</li><li>By decreasing left ventricular dP/dt and decreasing shear stress, beta blockers <strong>decrease the rate of aortic dilatation</strong>.</li><li>Beta blockers also decrease dP/dt and shear stress in the aorta.</li></ul></ul><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 164</p>",
      "correct_choice_id": 213,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Pemetrexed</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Palifermin</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">5-fluorouracil</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with choriocarcinoma was prescribed an anti-cancer drug and she returned with these lesions. Which of the following drugs could have prevented this side effect?<br><img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/23Q.png\"></span></p>",
      "unique_key": "Q185812",
      "question_audio": null,
      "question_video": null,
      "map_id": 185812,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong>Oral mucositis</strong> is a severe and frequent adverse effect of <strong>high-dose methotrexate (HD-MTX)</strong>-based chemotherapy. Mucositis usually occurs within the <strong>first 7 days</strong> of administration of MTX, prior to the onset of pancytopenia, as the accumulation of MTX is higher in mucosal epithelial cells than in the bone marrow stem cells.</li><li>Cutaneous involvement usually appears with mucositis.</li><li>Mucositis is associated with an increased risk of life-threatening infections, Need for total parenteral nutrition.. For many patients with grades III&ndash;IV mucositis, the subsequent cycle of chemotherapy is delayed. A <strong>grade IV mucositis is an emergency</strong> in oncology. the updated guidelines of the Multinational Association of Supportive Care in Cancer recommend the use of palifermin in patients who are receiving high-dose chemotherapy and total body irradiation with autologous stem-cell transplantation (level 1, grade A recommendation)</li><li>Mucositis is due to the <strong>direct drug toxicity in epithelial cells</strong>. Histologically, this toxicity is evidenced by <strong>severe keratinocyte necrosis</strong>.</li><li>Palifermin is a <strong>recombinant human keratinocyte growth factor (KGF)</strong> which is known to stimulate growth of epithelial cells in a wide variety of tissues. KGF receptors are present on epithelial cells in many tissues including the tongue, buccal mucosa, salivary gland, esophagus, stomach, intestine, lung, liver, pancreas, kidney, bladder, mammary gland and eye lens</li><li>Mechanism of action of palifermin in mucositis:<ul><li>Down-regulation of proinflammatory cytokines and <strong>increases anti-inflammatory cytokines such as IL-13</strong>.</li><li>Protection of the epithelium against reactive oxygen molecules by modifying the expression of detoxifying transcription factors and enzymes</li></ul></li></ul><p>Reference: Harrison's Principles of Internal Medicine, 21<sup>st</sup> edition, page no. 555-899</p>",
      "correct_choice_id": 222,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">1 only</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 3</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">1,2 and 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">35-years-old female, diagnosed with primary open angle glaucoma, was started on brimonidine topical therapy. After 1 week of treatment, her IOP has fallen from baseline level. Possible mechanism of action of brimonidine in this patient is:<br>1. Decreased aqueous secretion<br>2. Increased uveoscleral outflow<br>3. Increased trabecular outflow<br>4. Decreased hyperemia</span></p>",
      "unique_key": "Q185813",
      "question_audio": null,
      "question_video": null,
      "map_id": 185813,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>Brimonidine</strong> decreases IOP by 2 mechanisms:</p><ul><li><strong>Decreasing aqueous production</strong></li><li><strong>Increasing uveoscleral</strong> outflow</li></ul><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0;\"src=\"https://d10ehao5y6v0v4.cloudfront.net/TestseriesNew/PharmacologyFreeRev/24E.jpg\"><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 168</p>",
      "correct_choice_id": 232,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Gentamicin</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Amikacin</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Tobramycin</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Spectinomycin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-yr old female infected with Pseudomonas is to be treated with a combination of aminoglycoside and cephalosporin. Which of the following aminoglycosides is preferred?</span></p>",
      "unique_key": "Q185814",
      "question_audio": null,
      "question_video": null,
      "map_id": 185814,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li>There is an increased likelihood of synergistic nephrotoxic aminoglycoside-cephalosporin interaction.</li><li>There are two schools of thought towards combination therapy of Beta lactams(Cephalosporins) and Aminoglycoside.</li></ul><ol><li>The argument against the addition of a second antimicrobial agent to treat a Gram-negative organism that is susceptible to a single agent is that it may actually lead to increased antimicrobial resistance, adverse effects such as aminoglycoside-related nephrotoxicity.</li><li>The argument towards combination therapy may still be warranted for certain subpopulations &ndash; e.g.Profoundly neutropenic patients, patients with <em>Pseudomonas aeruginosa</em>sepsis, intensive care unit (ICU) patients, patients with VAP(Ventilaor-Associated Pneumonia), or septic patients with significantly elevated severity-of-illness scores.</li></ol><p><strong>NEPHROTOXICITY OF AMINOGLYCOSIDES:</strong></p><p>Aminoglycosides are nephrotoxic because a small but sizable proportion of the administered dose (&asymp;5%) is retained in the <strong>epithelial cells</strong> lining the <strong>S1 and S2 segments of the proximal tubules </strong>after glomerular filtration.</p><p><strong>Risk factors in aminoglycoside nephrotoxicity:</strong></p><ul><li>Dose and duration of drug treatment</li><li>Pre-existing renal insufficiency</li><li>Elderly age</li><li>Concomitant nephrotoxic drug administration</li><li>Volume depletion</li><li>Potassium depletion</li><li>Magnesium depletion</li></ul><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 799</p>",
      "correct_choice_id": 243,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">Ergotamine</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">Sumatriptan</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">Lorcaserin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 48-yr old woman with history of chronic migraine was admitted for inpatient management of interactable migraine headache. She suddenly developed abdominal pain, hypotension and diarrhea on the 10th day of admission.  Bedside colonoscopy image shown in the image. Which of the following drugs is most likely to have caused this adverse effect?<br><img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/26Q.png\"></span></p>",
      "unique_key": "Q185815",
      "question_audio": null,
      "question_video": null,
      "map_id": 185815,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>This is a case of diffuse ischemic colitis with fecal impaction which might be due to ergotamine induced vasospasm. It might prolong to bowel infarction, gangrene which may require surgical resection.</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 191</p>",
      "correct_choice_id": 251,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclopenthiazide</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">Indapamide</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">Chlorothiazide</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">Metolazone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 63-yr old male presented with swelling in both legs for 10 days. On examination, his urea and creatinine were raised and GFR was less than 20mL/min. Which of the following diuretic can be safely administered in this patient?</span></p>",
      "unique_key": "Q185816",
      "question_audio": null,
      "question_video": null,
      "map_id": 185816,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Metolazone -&gt; Both tubular secretion and glomerular filtration.</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 630</p>",
      "correct_choice_id": 264,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Lignocaine</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">Verapamil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs is avoided in a patient arrhythmia and pulmonary fibrosis?</span></p>",
      "unique_key": "Q185817",
      "question_audio": null,
      "question_video": null,
      "map_id": 185817,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong>Adverse effects of Amiodarone: (Mnemonic: NILESH)</strong></p><p>N -&gt; Neurotoxicity</p><p>I (High) High Vd, High Duration, High spectrum</p><p>L -&gt; Lungs Pulmonary fibrosis</p><p>E -&gt; Eyes &ndash; Corneal microdeposits</p><p>S -&gt; Smurf skin appearance</p><p>H -&gt; Hepatotoxicity (Pseudo alcoholic liver injury)</p><p>-&gt; Hypothyroidism &gt; Hyperthyroidism</p><p>-&gt; Hypertension</p><p>-&gt; Heart &ndash; Myocarditis</p><p><strong>DRUGS CAUSING PULMONARY FIBROSIS (Mnemonic: NICE BABE</strong>)</p><p>NI -&gt; Nitrofurantoin</p><p>CE -&gt; Cyclophosphamide</p><p>B -&gt; Bleomycin</p><p>A -&gt; Amiodarone</p><p>B -&gt; Busulfan</p><p>E -&gt; Ergot and its derivatives</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 578</p>",
      "correct_choice_id": 273,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29,
      "choices": [
        {
          "id": 281,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer amikacin at a dose of 5 mg/kg every 12 h</span></p>"
        },
        {
          "id": 282,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease the amikacin dose to daily total of 200 mg</span></p>"
        },
        {
          "id": 283,
          "text": "<p><span style=\"font-size:12.0pt;\">Discontinue amikacin and start on gentamicin</span></p>"
        },
        {
          "id": 284,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease the amikacin dose to 180 mg every 8 h</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient weighing 72kg with creatinine clearance of 80 mL/min develops a Gram-negative infection. Amikacin is administered intramuscularly at a dose of 5 mg/kg every 8 hrs and the patient begins to respond. After 2 days, creatinine clearance declines to 40 mL/min. Assuming that no information is available about amikacin plasma levels, what would be the most appropriate management for this patient?</span></p>",
      "unique_key": "Q185818",
      "question_audio": null,
      "question_video": null,
      "map_id": 185818,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Monitoring plasma drug levels is important when aminoglycosides are used. In this case, the patient seems to be improving, so a decrease of the amikacin dose in proportion to decreased creatinine clearance is most appropriate. Because creatinine clearance is only one half of the starting value, a dose reduction should be made to one half of that given initially.</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 796</p>",
      "correct_choice_id": 284,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30,
      "choices": [
        {
          "id": 291,
          "text": "<p><span style=\"font-size:12.0pt;\">Km increases, Vmax remains the same</span></p>"
        },
        {
          "id": 292,
          "text": "<p><span style=\"font-size:12.0pt;\">Km decreases, Vmax increases</span></p>"
        },
        {
          "id": 293,
          "text": "<p><span style=\"font-size:12.0pt;\">Km increases, Vmax increases</span></p>"
        },
        {
          "id": 294,
          "text": "<p><span style=\"font-size:12.0pt;\">Km remains the same, Vmax decreases</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">True about non-competitive inhibition is:</span></p>",
      "unique_key": "Q185819",
      "question_audio": null,
      "question_video": null,
      "map_id": 185819,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/30E.png\"><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 47</p>",
      "correct_choice_id": 294,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31,
      "choices": [
        {
          "id": 301,
          "text": "<p><span style=\"font-size:12.0pt;\">PDE-4 inhibition</span></p>"
        },
        {
          "id": 302,
          "text": "<p><span style=\"font-size:12.0pt;\">PDE-3 inhibition</span></p>"
        },
        {
          "id": 303,
          "text": "<p><span style=\"font-size:12.0pt;\">Alpha-1 antagonism</span></p>"
        },
        {
          "id": 304,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta blockade</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the mechanism by which theophylline produces diuresis?</span></p>",
      "unique_key": "Q185820",
      "question_audio": null,
      "question_video": null,
      "map_id": 185820,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/31E.png\"><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 245</p>",
      "correct_choice_id": 303,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32,
      "choices": [
        {
          "id": 311,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventricular arrhythmia</span></p>"
        },
        {
          "id": 312,
          "text": "<p><span style=\"font-size:12.0pt;\">Myopathy</span></p>"
        },
        {
          "id": 313,
          "text": "<p><span style=\"font-size:12.0pt;\">Electrolyte imbalance</span></p>"
        },
        {
          "id": 314,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephropathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Sparfloxacin and Astemizole can cause:</span></p>",
      "unique_key": "Q185821",
      "question_audio": null,
      "question_video": null,
      "map_id": 185821,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Other drugs causing torsades de pointes (Dancing around a point)</p><p>Zip dance in GTA</p><p>Zip -&gt; Ziprasidone</p><p>Dance -&gt; Torsades de pointes</p><p>G -&gt; Grepafloxacin</p><p>T -&gt; Terfenadine</p><p>A -&gt; Astemizole</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 764</p>",
      "correct_choice_id": 311,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33,
      "choices": [
        {
          "id": 321,
          "text": "<p><span style=\"font-size:12.0pt;\">Absorption of digoxin is delayed by presence of food</span></p>"
        },
        {
          "id": 322,
          "text": "<p><span style=\"font-size:12.0pt;\">Concurrent food intake may severely reduce the rate of absorption of phenytoin</span></p>"
        },
        {
          "id": 323,
          "text": "<p><span style=\"font-size:12.0pt;\">Presence of food enhances the absorption of hydrochlorothiazide</span></p>"
        },
        {
          "id": 324,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-malarial drug halofantrine is absorbed much better, if taken with food</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Food could interfere with drug absorption by slowing gastric emptying or by altering the degree of ionization of the drug in the stomach. Which of the following statements is not the correct example?</span></p>",
      "unique_key": "Q185822",
      "question_audio": null,
      "question_video": null,
      "map_id": 185822,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Presence of food in stomach delays absorption of digoxin and digitoxin Oral absorption of halofantrine is variable and enhanced with food. Food ingested has not been found to affect absorption of hydrochlorothiazide Absorption of phenytoin is slow mainly due to its poor solubility and not due to food intake.</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 440</p>",
      "correct_choice_id": 322,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34,
      "choices": [
        {
          "id": 331,
          "text": "<p><span style=\"font-size:12.0pt;\">Tachycardia</span></p>"
        },
        {
          "id": 332,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased diastolic perfusion time</span></p>"
        },
        {
          "id": 333,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased contractility</span></p>"
        },
        {
          "id": 334,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased collateral flow.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is NOT a deleterious effect of use of nitrates in angina?</span></p>",
      "unique_key": "Q185823",
      "question_audio": null,
      "question_video": null,
      "map_id": 185823,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Beneficial effects due to nitrates:</p><ol><li>Decreased ventricular volume</li><li>Decreased arterial pressure</li><li>Decreased ejection time</li><li>Vasodilation of epicardial arteries</li><li>Increased collateral flow</li><li>Decreased left ventricular diastolic pressure</li></ol><p>Deleterious effects due to nitrates:</p><ol><li>Reflex tachycardia</li><li>Reflex increase in contractility</li></ol><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 586</p>",
      "correct_choice_id": 334,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 35,
      "choices": [
        {
          "id": 341,
          "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-a, 3-c, 4-b</span></p>"
        },
        {
          "id": 342,
          "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-b, 3-a, 4-c</span></p>"
        },
        {
          "id": 343,
          "text": "<p><span style=\"font-size:12.0pt;\">1-b, 2-c, 3-d, 4-b</span></p>"
        },
        {
          "id": 344,
          "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-c, 3-a, 4-b</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the DMARD with its adverse effect<br><img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/35Q.png\"></span></p>",
      "unique_key": "Q185824",
      "question_audio": null,
      "question_video": null,
      "map_id": 185824,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/35E.png\"><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 229-230</p>",
      "correct_choice_id": 344,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 36,
      "choices": [
        {
          "id": 351,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta lactam antibiotics follow time-dependant killing of bacteria</span></p>"
        },
        {
          "id": 352,
          "text": "<p><span style=\"font-size:12.0pt;\">Cell membrane synthesis inhibitors follow concentration-dependent killing of bacteria</span></p>"
        },
        {
          "id": 353,
          "text": "<p><span style=\"font-size:12.0pt;\">Drugs with time-dependant killing have to administered as multiple daily doses</span></p>"
        },
        {
          "id": 354,
          "text": "<p><span style=\"font-size:12.0pt;\">Drugs with concentration-dependent killing have less post antibiotic effect than drugs with time-dependant killing</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Find the FALSE statement regarding bactericidal drugs:</span></p>",
      "unique_key": "Q185825",
      "question_audio": null,
      "question_video": null,
      "map_id": 185825,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Drugs following CDK has less post antibiotic effect than drugs following TDK</p><p>Aminoglycosides exert concentration dependent bactericidal action and a long as well as concentration dependent post-antibiotic effect. Therefore higher plasma concentrations attained after the single daily dose will be equally or more effective than the divided doses.</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 796</p>",
      "correct_choice_id": 354,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 37,
      "choices": [
        {
          "id": 361,
          "text": "<p><span style=\"font-size:12.0pt;\">He must continue allopurinol throughout life</span></p>"
        },
        {
          "id": 362,
          "text": "<p><span style=\"font-size:12.0pt;\">Discontinue allopurinol 3 months after achieving target serum uric acid level</span></p>"
        },
        {
          "id": 363,
          "text": "<p><span style=\"font-size:12.0pt;\">Discontinue allopurinol 6 months after achieving target serum uric acid level</span></p>"
        },
        {
          "id": 364,
          "text": "<p><span style=\"font-size:12.0pt;\">Discontinue allopurinol 1 year after achieving target serum uric acid level</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-yr old male with a diagnosis of acute gout without tophi was managed successfully with medical therapy. He was started on long term urate lowering therapy with Allopurinol. Which of the following conditions is true regarding continuation/cessation of allopurinol in this patient?</span></p>",
      "unique_key": "Q185826",
      "question_audio": null,
      "question_video": null,
      "map_id": 185826,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Prophylaxis of acute gout with ULT:</p><ul><li>Atleast 6 month duration</li><li>Acute gout without tophi: 3 months after achieving target SUA</li><li>Acute gout with tophi: 6 months after achieving target SUA</li></ul><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 234-235</p>",
      "correct_choice_id": 362,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38,
      "choices": [
        {
          "id": 371,
          "text": "<p><span style=\"font-size:12.0pt;\">Bronchodilatation</span></p>"
        },
        {
          "id": 372,
          "text": "<p><span style=\"font-size:12.0pt;\">Bronchoprotection</span></p>"
        },
        {
          "id": 373,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac arrhythmia</span></p>"
        },
        {
          "id": 374,
          "text": "<p><span style=\"font-size:12.0pt;\">Tremor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Administering inhaled corticosteroids along with beta-2 agonists results in tolerance to certain effects of the latter. Which of the following is an exception to this?</span></p>",
      "unique_key": "Q185827",
      "question_audio": null,
      "question_video": null,
      "map_id": 185827,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Because, Steroids fail to reach airway smooth muscles in high enough concentrations like beta 2 agonists.</p><p><strong>Inhaled corticosteroids</strong></p><p>These are glucocorticoids with high topical and low systemic activity (due to poor absorption and/or marked first pass metabolism).</p><p>Beclomethasone dipropionate, Budesonide, Fluticasone and Ciclesonide are the commonly used ICS. Because airway inflammation is present in early mild disease as well, and bronchial remodeling starts developing from the beginning, it has been advocated that ICS should be the &lsquo;step one&rsquo; for all asthma patients.</p><p>They are indicated in all cases of persistent asthma when inhaled &beta;2 agonists are required almost daily or the disease is not only episodic.</p><p>Inhaled corticosteroids suppress bronchial inflammation, increase peak expiratory flow rate, reduce need for rescue &beta;2-agonist inhalations and prevent episodes of acute asthma.</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 250</p>",
      "correct_choice_id": 372,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 39,
      "choices": [
        {
          "id": 381,
          "text": "<p><span style=\"font-size:12.0pt;\">Indomethacin</span></p>"
        },
        {
          "id": 382,
          "text": "<p><span style=\"font-size:12.0pt;\">Sildenafil</span></p>"
        },
        {
          "id": 383,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        },
        {
          "id": 384,
          "text": "<p><span style=\"font-size:12.0pt;\">Reassurance</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 27-yr old male, on treatment with lithium, visited OPD and complains of decreased libido and erectile dysfunction. Which of the following is not an option in managing his condition?</span></p>",
      "unique_key": "Q185828",
      "question_audio": null,
      "question_video": null,
      "map_id": 185828,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Aspirin (240 mg &ndash; administered daily), and PDE-V inhibitors (Sildenafil) can be administered for treating ED among lithium patients.</p><p>Though Indomethacin is effective, it also increases reabsorption of lithium from PCT causing drug accumulation leading onto toxicity symptoms, so its avoided.</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 327</p>",
      "correct_choice_id": 381,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 40,
      "choices": [
        {
          "id": 391,
          "text": "<p><span style=\"font-size:12.0pt;\">Withdrawal of medications in patients who are seizure-free for 1 year</span></p>"
        },
        {
          "id": 392,
          "text": "<p><span style=\"font-size:12.0pt;\">Withdrawal must be gradual</span></p>"
        },
        {
          "id": 393,
          "text": "<p><span style=\"font-size:12.0pt;\">After withdrawal, previous effective regimen is reinstituted in case of recurrence of seizures</span></p>"
        },
        {
          "id": 394,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcohol withdrawal seizures are usually self-limiting</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements about management of epilepsy is false?</span></p>",
      "unique_key": "Q185829",
      "question_audio": null,
      "question_video": null,
      "map_id": 185829,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Gradual withdrawal of medications are tried in patients who are seizure free for more than 2 years</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 448-449</p>",
      "correct_choice_id": 391,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 41,
      "choices": [
        {
          "id": 401,
          "text": "<p><span style=\"font-size:12.0pt;\">Topiramate should be started at high dose because valproate is a microsomal enzyme inducer</span></p>"
        },
        {
          "id": 402,
          "text": "<p><span style=\"font-size:12.0pt;\">Dose of valproate is increased to increase its efficacy</span></p>"
        },
        {
          "id": 403,
          "text": "<p><span style=\"font-size:12.0pt;\">Topiramate should be started at low dose because valproate is a microsomal enzyme inhibitor</span></p>"
        },
        {
          "id": 404,
          "text": "<p><span style=\"font-size:12.0pt;\">Topiramate is started without any alteration in dose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 39-yr old female patient diagnosed with generalized tonic-clonic seizures was started on valproate. She reports back to the OPD with poor control of seizures. Topiramate was added to the regimen. What will be the next step in management of this patient?</span></p>",
      "unique_key": "Q185830",
      "question_audio": null,
      "question_video": null,
      "map_id": 185830,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Valproate is a microsomal enzyme inhibitor.</p><p>Any anti-epileptic agents&rsquo; dose, when given with valproate, needs to be decreased as the enzymes are inhibited and the metabolism of the drug gets compromised (Especially seen with Lamotrigene, Phenytoin and Carbamazepine).</p><p>But dose need not be decreased for Topiramate, Gabapentin and vigabatrin as these drugs are primarily excreted unchanged.</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 447</p>",
      "correct_choice_id": 404,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 42,
      "choices": [
        {
          "id": 411,
          "text": "<p><span style=\"font-size:12.0pt;\">0.4 mmol/L</span></p>"
        },
        {
          "id": 412,
          "text": "<p><span style=\"font-size:12.0pt;\">0.8 mmol/L</span></p>"
        },
        {
          "id": 413,
          "text": "<p><span style=\"font-size:12.0pt;\">1.6 mmol/L</span></p>"
        },
        {
          "id": 414,
          "text": "<p><span style=\"font-size:12.0pt;\">3.2 mmol/L</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-yr old male under treatment with lithium, complains of continuous fever and decreased urine output for the past 4 days. What is the plasma concentration of lithium that is associated with the adverse effect seen in this patient?</span></p>",
      "unique_key": "Q185831",
      "question_audio": null,
      "question_video": null,
      "map_id": 185831,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Plasma concentrations of more than 2 mmol/L is associated with</p><p>- Hyperreflexia</p><p>- Hyperextension of limbs</p><p>- Seizures</p><p>- Hyperthermia</p><p>- Toxic psychoses</p><p>- Oliguria</p><p>- Coma and death.</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 476</p>",
      "correct_choice_id": 414,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43,
      "choices": [
        {
          "id": 421,
          "text": "<p><span style=\"font-size:12.0pt;\">Reduction in HDAC2 expression</span></p>"
        },
        {
          "id": 422,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased HDAC2 expression</span></p>"
        },
        {
          "id": 423,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased eosinophil survival</span></p>"
        },
        {
          "id": 424,
          "text": "<p><span style=\"font-size:12.0pt;\">Enhanced bronchoconstriction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The possible mechanism of steroid-resistant asthma is</span></p>",
      "unique_key": "Q185832",
      "question_audio": null,
      "question_video": null,
      "map_id": 185832,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Reversible by adding low-dose theophylline and nortriptyline</p><p>Corticosteroid resistance is a major barrier to effective therapy in patients with severe asthma, in asthmatic patients who smoke, and in patients with COPD and cystic fibrosis.</p><p>&ldquo;Steroid-resistant&rdquo; asthma is thought to be due to reduced anti-inflammatory actions of corticosteroids. In patients with COPD and some patients with severe asthma, there is a reduction in HDAC2 expression that reduces corticos&shy;teroid responsiveness; this is potentially reversible by theophylline.</p><p>Reference: Goodman and Gilman&rsquo;s The Pharmacological Basis of therapeutics, 14<sup>th</sup> edition, page no. 889</p>",
      "correct_choice_id": 421,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44,
      "choices": [
        {
          "id": 431,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreases serum uric acid levels without any effect on urinary uric acid levels</span></p>"
        },
        {
          "id": 432,
          "text": "<p><span style=\"font-size:12.0pt;\">Dose is reduces when given with thioguanine</span></p>"
        },
        {
          "id": 433,
          "text": "<p><span style=\"font-size:12.0pt;\">It produces a dose-independent reversible competitive inhibition of xanthine oxidase</span></p>"
        },
        {
          "id": 434,
          "text": "<p><span style=\"font-size:12.0pt;\">Allopurinol is initiated with NSAIDs to prevent acute flare-up of gout</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statement regarding allopurinol is TRUE?</span></p>",
      "unique_key": "Q185833",
      "question_audio": null,
      "question_video": null,
      "map_id": 185833,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Decreases both serum and urinary uric acid levels</p><p>- No need for dose reduction with thioguanine</p><p>- At low doses &ndash; Competitive reversible inhibition</p><p>- At high doses &ndash; Non-competitive irreversible inhibition</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 235</p>",
      "correct_choice_id": 434,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 45,
      "choices": [
        {
          "id": 441,
          "text": "<p><span style=\"font-size:12.0pt;\">Cycloplegia</span></p>"
        },
        {
          "id": 442,
          "text": "<p><span style=\"font-size:12.0pt;\">Dry skin in warm environment</span></p>"
        },
        {
          "id": 443,
          "text": "<p><span style=\"font-size:12.0pt;\">Miosis</span></p>"
        },
        {
          "id": 444,
          "text": "<p><span style=\"font-size:12.0pt;\">Postural hypotension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-yr old man has been treated with a drug acting on the autonomic system for 4 weeks. He is now admitted with signs of drug toxicity. Which of the following signs would distinguish between an overdose of ganglion blocker and a muscarinic blocker?</span></p>",
      "unique_key": "Q185834",
      "question_audio": null,
      "question_video": null,
      "map_id": 185834,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Neither ganglion blockers nor muscarinic blockers cause miosis; they cause mydriasis. Both classes of cholinoceptor blockers increase resting heart rate and cause cycloplegia, because these are determined largely by parasympathetic tone. Similarly, both can cause dry skin, since this requires cholinergic transmission. Postural hypotension, on the other hand, is a sign of sympathetic blockade, which would occur with ganglion blockers but not muscarinic blockers</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 135</p>",
      "correct_choice_id": 444,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 46,
      "choices": [
        {
          "id": 451,
          "text": "<p><span style=\"font-size:12.0pt;\">Prevents potassium depletion</span></p>"
        },
        {
          "id": 452,
          "text": "<p><span style=\"font-size:12.0pt;\">Increases Sodium excretion</span></p>"
        },
        {
          "id": 453,
          "text": "<p><span style=\"font-size:12.0pt;\">Prevents adaptation to therapy</span></p>"
        },
        {
          "id": 454,
          "text": "<p><span style=\"font-size:12.0pt;\">Prevents nephron loss and progression to renal failure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">'Sequential nephron blockade' with diuretics has the following advantage:</span></p>",
      "unique_key": "Q185835",
      "question_audio": null,
      "question_video": null,
      "map_id": 185835,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Resistance to diuretics can develop by</p><ol><li>Pharmacokinetic mechanism &ndash; Amount of free diuretic reaching the site of action and diuretic&rsquo;s time course of delivery to urine.</li><li>Pharmacodynamic mechanism &ndash; The effect of diuretics can be counteracted by adaptation response which increases reabsorption of sodium in other areas of nephron.</li></ol><p>This resistance development can be prevented by administering loop diuretics and thiazides together, which tend to block the reabsorption of sodium in various parts of the nephron which prevents the development of adaptation.</p><p>Reference: Goodman and Gilman's The Pharmacological Basis of therapeutics, 14<sup>th</sup> edition, page no. 571</p>",
      "correct_choice_id": 453,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47,
      "choices": [
        {
          "id": 461,
          "text": "<p><span style=\"font-size:12.0pt;\">It increases the formation of plasminogen</span></p>"
        },
        {
          "id": 462,
          "text": "<p><span style=\"font-size:12.0pt;\">It is less effective than streptokinase when given after myocardial infarction</span></p>"
        },
        {
          "id": 463,
          "text": "<p><span style=\"font-size:12.0pt;\">Has a high incidence of thrombocytopenia</span></p>"
        },
        {
          "id": 464,
          "text": "<p><span style=\"font-size:12.0pt;\">It may cause bleeding that is reversible by aminocaproic acid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is true regarding the parenteral administration of alteplase?</span></p>",
      "unique_key": "Q185836",
      "question_audio": null,
      "question_video": null,
      "map_id": 185836,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p>Alteplase is thrombolytic (or &ldquo;fibrinolytic&rdquo;) because it activates plasminogen, resulting in the increased formation of plasmin. Its efficacy is equivalent to that of streptokinase, but alteplase has the advantage of only activating plasminogen bound to fibrin (clot specific) but not free plasminogen. All thrombolytics can cause bleeding, which may be counteracted to some extent by administration of antifibrinolysins, such as aminocaproic acid.</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 674</p>",
      "correct_choice_id": 464,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 48,
      "choices": [
        {
          "id": 471,
          "text": "<p><span style=\"font-size:12.0pt;\">Drug A</span></p>"
        },
        {
          "id": 472,
          "text": "<p><span style=\"font-size:12.0pt;\">Drug B</span></p>"
        },
        {
          "id": 473,
          "text": "<p><span style=\"font-size:12.0pt;\">Drug C</span></p>"
        },
        {
          "id": 474,
          "text": "<p><span style=\"font-size:12.0pt;\">Both A & B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which drug, depicted in the graph below, has high potency?<br><img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/48Q.png\"></span></p>",
      "unique_key": "Q185837",
      "question_audio": null,
      "question_video": null,
      "map_id": 185837,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/48E.png\"><br><p>DRC - Dose response curve</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 64-65</p>",
      "correct_choice_id": 471,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 49,
      "choices": [
        {
          "id": 481,
          "text": "<p><span style=\"font-size:12.0pt;\">Lignocaine</span></p>"
        },
        {
          "id": 482,
          "text": "<p><span style=\"font-size:12.0pt;\">Quinine</span></p>"
        },
        {
          "id": 483,
          "text": "<p><span style=\"font-size:12.0pt;\">Meropenem</span></p>"
        },
        {
          "id": 484,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following drugs worsens myasthenia gravis except:</span></p>",
      "unique_key": "Q185838",
      "question_audio": null,
      "question_video": null,
      "map_id": 185838,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/49E.png\"><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 782</p>",
      "correct_choice_id": 483,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50,
      "choices": [
        {
          "id": 491,
          "text": "<p><span style=\"font-size:12.0pt;\">Posaconazole</span></p>"
        },
        {
          "id": 492,
          "text": "<p><span style=\"font-size:12.0pt;\">Voriconazole</span></p>"
        },
        {
          "id": 493,
          "text": "<p><span style=\"font-size:12.0pt;\">Liposomal Amphotericin B</span></p>"
        },
        {
          "id": 494,
          "text": "<p><span style=\"font-size:12.0pt;\">Caspofungin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Drug of choice for invasive aspergillosis:</span></p>",
      "unique_key": "Q185839",
      "question_audio": null,
      "question_video": null,
      "map_id": 185839,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<img style=\"max-width: 350px;max-height: 350px\" src=\"https://d1mobye7msb5bl.cloudfront.net/Quiz/05022021/50E.png\"><br><p>Voriconazole: (Second generation broad spectrum triazole)</p><p>DOC:</p><ul><li>Invasive aspergillosis</li><li>Fluconazole resistant candida</li><li>Anti-bacterial therapy resistant febrile neutropenia</li></ul><p>Reference: Essentials of Medical Pharmacology by KD Tripathi, 8<sup>th</sup> edition, page no. 846</p>",
      "correct_choice_id": 492,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}